Multicentric validation of a Multimorbidity Adjusted Disability Score to stratify depression-related risks using temporal disease maps
Gonzalez-Colom, R.; Mitra, K.; Vela, E.; Gezsi, A.; Paajanen, T.; Gal, Z.; Hullam, G.; Makinen, H.; Nagy, T.; Kuokkanen, M.; Piera-Jimenez, J.; Roca, J.; Antal, P.; Juhasz, G.; Cano, I.
Show abstract
In the EU project TRAJECTOME, we used a novel methodology to identify temporal disease maps of depression and highly prevalent co-occurring disease conditions. This information was combined with disability weights established by the Global Burden of Disease Study 2019 to create a depression-related health risk assessment tool, the Multimorbidity Adjusted Disability Score (MADS). MADS was used to stratify over one million cases from three different cohorts and evaluate the impact on utilisation of healthcare resources, mortality, pharmacological burden, healthcare expenditure and multimorbidity progression. Results indicate statistically significant associations between MADS and increased mortality rate (P <.001), heightened healthcare utilization (i.e. emergency room visits P <.001; hospitalizations P <.001; pharmaceutical prescriptions P <.001; total healthcare expenditure P <.001), and a higher risk of disease progression and incidence of new depression-related comorbidities. MADS seems to be a promising approach to predict depression-related health risk and depressions impact on individuals and healthcare systems, which can be tested in other diseases; nevertheless, clinical validation is still necessary.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Multiple measures of depression to enhance validity of Major Depressive Disorder in the UK Biobank 94%
- The prevalence, incidence, prognosis and risk factors for depression and anxiety in a UK cohort during the COVID-19 pandemic 92%
- The consequences of a year of the COVID-19 pandemic for the mental health of young adult twins in England and Wales 92%
Similar papers in this journal
- Cross-continental environmental and genome-wide association study on children and adolescent anxiety and depression 92%
- Mental and social health of children and adolescents with pre-existing mental or somatic problems during the COVID-19 pandemic lockdown 92%
- Patients with affective disorders profit most from telemedical treatment: Evidence from a naturalistic patient cohort during the COVID-19 pandemic 92%
Similar papers in this journal
- Understanding genetic risk factors for common side effects of antidepressant medications 92%
- Sex-specific transcriptome similarity networks elucidate comorbidity relationships 91%
- Metabolic Hormone and Adipokine Alterations in Major Depressive Disorder in Relation to the Acute-Phase Inflammatory Response and Early-Life Adversity 90%
Similar papers in this journal
- A mesocorticolimbic dopamine gene network moderates the effect of early adversity on the risk for psychiatric and cardio-metabolic comorbidities 93%
- The influence of repeated mild lockdown on mental and physical health during the COVID-19 pandemic: a large-scale longitudinal study in Japan 92%
- Exposotypes in Psychotic Disorders 91%
Similar papers in this journal
- Cross-phenotype relationship between opioid use disorder and suicide attempts: new evidence from polygenic association and Mendelian randomization analyses 93%
- Polygenic prediction of major depressive disorder and related traits in African ancestries UK Biobank participants 93%
- Similarities and dissimilarities between psychiatric cluster disorders 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.